INVENTIVA SA - ADR

IVA03 Dec 2024
Healthcare
$2.65
-0.02 (-1.51%)
Lowest Today
$2.6
Highest Today
$2.7
Today’s Open
$2.65
Prev. Close
$2.65
52 Week High
$4.75
52 Week Low
$1.53
BUY
SELL
To Invest in INVENTIVA SA - ADR

INVENTIVA SA - ADR

Healthcare
IVA03 Dec 2024
₹
-0.02 (-1.51%)
1M
3M
6M
1Y
5Y
Low
$2.6
Day’s Range
High
$2.7
2.6
52 Week Low
$1.53
52-Week Range
52 Week High
$4.75
1.53
1 Day
-
1 Week
-
1 month return
-6.54%
3 month return
+17.88%
6 month return
-19.93%
1 Year return
-43.51%
3 Years return
-80.86%
5 Years return
-
10 Years return
-
Institutional Holdings
Yiheng Capital LLC
5.05
NEA Management Company, LLC
2.79
Bvf Inc
1.31
Commonwealth Equity Services Inc
0.08
Susquehanna International Group, LLP
0.03
Fidelity Nasdaq Composite Index
0.01
Morgan Stanley - Brokerage Accounts
0

Market Status

Fundamentals
Market Cap
229.75 mln
PB Ratio
2.1
PE Ratio
0
Enterprise Value
175.86 mln
Total Assets
69.56 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Organisation
INVENTIVA SA - ADR
Employees
123
Industry
Biotechnology
CEO
Mr. Frederic  Cren
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Get expert assistance for portfolio management

BUY
SELL
Click here to see your activities